April 20th, 2012
Actos Whistleblower Suit Unsealed In late February 2012, U.S. District Court Judge F. Dennis Saylor unsealed a qui tam whistleblower lawsuit, alleging that a doctor contracting with Takeda Pharmaceuticals, the manufacturer of Actos, was met with resistance from her superiors at Takeda when she attempted to report Actos bladder cancer findings. Dr. Helen Ge claimed that Takeda hired her under contract in September of 2008 and charged her with the task of reviewing various drugs in the Takeda portfolio for
Read More...
April 13th, 2012
A recent study from the National Joint Registry of English and Wales found that 6% of people with metal-on-metal implants needed additional surgery. This percentage is high when compared to the 1.7 to 2.4% rate found in individuals with ceramic or plastic hips. Study author Ashley Blom, head of orthopedic research at the University of Bristol, stated that with so many hip replacement alternatives, there was no reason to take the risk that comes with metal-on-metal hips. “If I were
Read More...
April 9th, 2012
The Food and Drug Administration (FDA) has responded to the continued concern of Metal-on-Metal hip implants by announcing a public meeting to discuss the safety and effectiveness of Metal-on-Metal hip implant devices. On June 27 and 28, 2012, the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee, which is part of the FDA, will meet to discuss Metal-on-Metal hip implants and consider whether more rigorous testing standards are needed. According to the meeting announcement on the FDA’s
Read More...
April 2nd, 2012
Update of Cases Pope McGlamry is Currently Pursuing For over 28 years, Pope McGlamry has been at the forefront of all types of complex litigation, including products liability claims, claims involving defective pharmaceutical drugs, class actions, and personal injury claims involving catastrophic injury or wrongful death. Below is a list of some of the specific cases Pope McGlamry is currently pursuing. Products Liability DePuy ASR Hip Implant System DePuy Orthopaedics, a subsidiary of Johnson & Johnson, recalled
Read More...
March 26th, 2012
The New York Times Reports that DePuy Orthopaedics, Inc.’s Decision to Phase Out its ASR Hip Implant Devices followed an FDA Data Request When it comes to the timing of DePuy Orthopaedic, Inc.’s (“DePuy’s”) recall of its ASR hip implant devices, it is important to understand what DePuy knew about the safety and effectiveness of the hip implants and when they knew it. A recent New York Times article reminds us that DePuy, a unit of Johnson & Johnson, manufactured
Read More...
